Factors Associated with Nodal Upstaging in Clinical T1a-bN0M0 Non-Small Cell Lung Cancers

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Mar 10

PMID 35267588

Authors

Tung-Ming Tsai

Chao-Yu Liu

Mong-Wei Lin

Hsao-Hsun Hsu

Jin-Shing Chen

Affiliations

Soon will be listed here.

Abstract

Nodal upstaging of lung adenocarcinoma occurs when unexpected pathological lymph node metastasis is found after surgical intervention, and may be associated with a worse prognosis. In this study, we aimed to determine the predictive factors of nodal upstaging in cT1a-bN0M0 primary lung adenocarcinoma. We retrospectively reviewed a prospective database (January 2011 to May 2017) at National Taiwan University Hospital and identified patients with cT1a-bN0M0 (solid part tumor diameter ≤ 2 cm) lung adenocarcinoma who underwent video-assisted thoracoscopic lobectomy. Logistic regression models and survival analysis were used to examine and compare the predictive factors of nodal upstaging. A total of 352 patients were included. Among them, 28 (7.8%) patients had nodal upstaging. Abnormal preoperative serum carcinoembryonic antigen (CEA) levels, solid part tumor diameter ≥ 1.3 cm, and consolidation-tumor (C/T) ratio ≥ 0.50 on chest computed tomography (CT) were significant predictive factors associated with nodal upstaging, and patients with nodal upstaging tended to have worse survival. Standard lobectomy is recommended for patients with these predictive factors. If neither of the predictive factors are positive, a less invasive procedure may be a reasonable alternative. Further studies are needed to verify these data.

Citing Articles

Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience.

Manfredini B, Zirafa C, Stefani A, Romano G, Ali G, Morganti R Curr Oncol. 2025; 32(1.

PMID: 39851947 PMC: 11763634. DOI: 10.3390/curroncol32010031.

Imaging diagnostics of pulmonary ground-glass nodules: a narrative review with current status and future directions.

Luo W, Ren Y, Liu Y, Deng J, Huang X Quant Imaging Med Surg. 2024; 14(8):6123-6146.

PMID: 39144060 PMC: 11320543. DOI: 10.21037/qims-24-674.

The prognostic significance of right paratracheal lymph node dissection numbers in right upper lobe non-small cell lung cancer.

Zhuang F, Lin J, Chen W, Chen X, Chen Y, Wang P Updates Surg. 2024; 76(5):1899-1908.

PMID: 38418693 PMC: 11455854. DOI: 10.1007/s13304-024-01778-7.

Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer.

Li Z, Pan C, Xu W, Zhao C, Pan X, Wang Z Respir Res. 2024; 25(1):96.

PMID: 38383329 PMC: 10880259. DOI: 10.1186/s12931-024-02727-z.

Influencing Factors on the Quality of Lymph Node Dissection for Stage IA Non-Small Cell Lung Cancer: A Retrospective Nationwide Cohort Study.

Gabryel P, Skrzypczak P, Roszak M, Campisi A, Zielinska D, Bryl M Cancers (Basel). 2024; 16(2).

PMID: 38254835 PMC: 10814584. DOI: 10.3390/cancers16020346.

References

Patel V, Naik S, Naidich D, Travis W, Weingarten J, Lazzaro R . A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest. 2013; 143(3):825-839. DOI: 10.1378/chest.12-0960. View

De Leyn P, Vansteenkiste J, Cuypers P, Deneffe G, Van Raemdonck D, Coosemans W . Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg. 1998; 12(5):706-12. DOI: 10.1016/s1010-7940(97)00253-4. View

Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K . A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011; 6(4):751-6. DOI: 10.1097/JTO.0b013e31821038ab. View

Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K . Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis. Ann Thorac Surg. 2018; 106(4):989-997. DOI: 10.1016/j.athoracsur.2018.04.069. View

Ho C, Tong K, Ramsden K, Ionescu D, Laskin J . Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified. Curr Oncol. 2015; 22(3):e164-70. PMC: 4462538. DOI: 10.3747/co.22.2339. View

Lin Y, Chen C, Hsieh C, Hsu W, Wu Y, Hung J . Lymphadenectomy is Unnecessary for Pure Ground-Glass Opacity Pulmonary Nodules. J Clin Med. 2020; 9(3). PMC: 7141214. DOI: 10.3390/jcm9030672. View

Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, NARUKE T . Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?. J Thorac Cardiovasc Surg. 1996; 111(6):1125-34. DOI: 10.1016/s0022-5223(96)70213-1. View

Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K . Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer. Ann Thorac Surg. 2016; 102(2):407-15. DOI: 10.1016/j.athoracsur.2016.02.074. View

Silvestri G, Gonzalez A, Jantz M, Margolis M, Gould M, Tanoue L . Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):e211S-e250S. DOI: 10.1378/chest.12-2355. View

10.

Lee P, Port J, Korst R, Liss Y, Meherally D, Altorki N . Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2007; 84(1):177-81. DOI: 10.1016/j.athoracsur.2007.03.081. View

11.

De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R . Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014; 45(5):787-98. DOI: 10.1093/ejcts/ezu028. View

12.

Haruki T, Aokage K, Miyoshi T, Hishida T, Ishii G, Yoshida J . Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection. J Thorac Oncol. 2015; 10(6):930-6. DOI: 10.1097/JTO.0000000000000546. View

13.

Vansteenkiste J, Crino L, Dooms C, Douillard J, Faivre-Finn C, Lim E . 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014; 25(8):1462-74. DOI: 10.1093/annonc/mdu089. View

14.

Koike T, Koike T, Yamato Y, Yoshiya K, Toyabe S . Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J Thorac Oncol. 2012; 7(8):1246-51. DOI: 10.1097/JTO.0b013e31825871de. View

15.

Boffa D, Kosinski A, Paul S, Mitchell J, Onaitis M . Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg. 2012; 94(2):347-53. DOI: 10.1016/j.athoracsur.2012.04.059. View

16.

Ito H, Suzuki K, Mizutani T, Aokage K, Wakabayashi M, Fukuda H . Long-term survival outcome after lobectomy in patients with clinical T1 N0 lung cancer. J Thorac Cardiovasc Surg. 2020; . DOI: 10.1016/j.jtcvs.2019.12.072. View

17.

Licht P, Jorgensen O, Ladegaard L, Jakobsen E . A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg. 2013; 96(3):943-9. DOI: 10.1016/j.athoracsur.2013.04.011. View

18.

Toker A, Ozyurtkan M, Kaba E . Nodal upstaging: effects of instrumentation and three-dimensional view in clinical stage I lung cancer. J Vis Surg. 2017; 3:76. PMC: 5637819. DOI: 10.21037/jovs.2017.04.05. View

19.

Shimamatsu S, Takenoyama M, Shimokawa M, Takada K, Edagawa M, Toyozawa R . The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung Cancer. Ann Thorac Surg. 2019; 108(4):1080-1086. DOI: 10.1016/j.athoracsur.2019.04.026. View

20.

Moon Y, Choi S, Park J, Lee K . Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less. World J Surg. 2020; 44(5):1658-1665. DOI: 10.1007/s00268-019-05365-5. View